Perrigo Projects Adjusted EPS of $2.25-$2.45 Following Reclassification of Infant Formula
Perrigo (PRGO) has provided updated financial guidance, projecting an all-in adjusted earnings per share (EPS) in the range of $2.25 to $2.45. This adjustment follows a strategic decision to move its infant formula business into discontinued operations, aiming to streamline the company's portfolio. Interim President and CEO Albert Manzone emphasized that the company is undergoing a period of simplification to address increasing organizational complexity. Management intends to take decisive actions to strengthen the core business by being more deliberate in their operational focus and resource allocation.
Tickers: $PRGO
Topics: Corporate Restructuring Executive Leadership Simplification Strategy
Read the full article at Seeking Alpha
Part of the story Perrigo Announces Divestment of Infant Formula Business to Focus on High-Margin Self-Care Products (3 articles)